do-me/EUR-LEX huggingface dataset:
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2022/C 130/09
Date: 2022-03-23
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: chemical compound, chemical product, health control, health risk, market approval, marketing standard, pharmaceutical industry








C_2022130EN.01001101.xml










23.3.2022   


EN


Official Journal of the European Union


C 130/11






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)


(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))

(Text with EEA relevance)
(2022/C 130/09)

Decision granting an authorisation













Reference of the decision (2)



Date of decision


Substance name


Holder of the authorisation


Authorisation number


Authorised use


Date of expiry of review period


Reasons for the decision




C(2022) 1497


16 March 2022


4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated
(4-tert-OPnEO)
EC No: -, CAS No:-


Eli Lilly Kinsale Limited, Dunderrow, Kinsale, P17 NY71 Cork, Co. Cork Ireland


REACH/22/6/0


Industrial use as a patient safety viral inactivation reagent in the manufacture of human medicines produced from biological systems


4 January 2033


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies.






(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).
Case T-757/20: Judgment of the General Court of 23 March 2022 — OT v Parliament (Civil service — Officials — Disciplinary penalty — Reprimand — Article 21a of the Staff Regulations — Error of assessment)
Date: 2022-03-23
Institutions: General Court
Subjects: European official, administrative sanction, disciplinary proceedings, staff regulations (EU), whistleblowing








C_2022198EN.01003901.xml










16.5.2022   


EN


Official Journal of the European Union


C 198/39






Judgment of the General Court of 23 March 2022 — OT v Parliament
(Case T-757/20) (1)

(Civil service - Officials - Disciplinary penalty - Reprimand - Article 21a of the Staff Regulations - Error of assessment)
(2022/C 198/55)
Language of the case: French

Parties


Applicant: OT (represented by: C. Bernard-Glanz and S. Rodrigues, lawyers)

Defendant: European Parliament (represented by: I. Lázaro Betancor and M. Windisch, acting as Agents)

Re:

Application under Article 270 TFEU seeking annulment of the decision of the Parliament of 19 December 2019 imposing a reprimand on the applicant.

Operative part of the judgment

The Court:






1.


Annuls the decision of the European Parliament of 19 December 2019 imposing a reprimand on the applicant;










2.


Orders the Parliament to pay the costs.






(1)  OJ C 62, 22.2.2021.